Robert Andrade, CHIEF FINANCIAL OFFICER at FENNEC PHARMACEUTICALS INC. (FENC), sold 30,000 shares at $10.41 ($316K) on 2024-01-05, disclosed to the SEC on 2024-01-05.
Scheduled sale ($316k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.64 | 15,000 | $160K | 50.5% |
| 2 | $10.41 | 15,000 | $156K | 49.5% |
| Total | $10.53 avg | 30,000 | $316K | 100% |
| Filing → |
| FENC | SELL | 2024-03-25 | $154K | — | Filing → |
| FENC | SELL | 2023-06-30 | $223K | — | Filing → |
| FENC | SELL | 2022-12-30 | $211K | — | Filing → |